10x Genomics Inc Stock Ownership - Who owns 10x Genomics?

Insider buying vs selling

Have 10x Genomics Inc insiders been buying or selling?
James WilburChief Commercial Officer2023-05-23316$55.07
Benjamin J. HindsonPresident and Chief Scientific Officer2023-05-23619$55.06
Benjamin J. HindsonPresident and Chief Scientific Officer2023-05-23243$55.06
Benjamin J. HindsonPresident and Chief Scientific Officer2023-05-23791$55.06
Benjamin J. HindsonPresident and Chief Scientific Officer2023-05-23735$55.06
Justin J. McAnearChief Financial Officer2023-05-23565$55.06
Justin J. McAnearChief Financial Officer2023-05-23441$55.06
Justin J. McAnearChief Financial Officer2023-05-23465$55.06
Justin J. McAnearChief Financial Officer2023-05-23194$55.07
Serge SaxonovChief Executive Officer2023-05-232,068$55.06

1 of 4

TXG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXG insiders and whales buy or sell their stock.

TXG Shareholders

What type of owners hold 10x Genomics Inc stock?
Morgan Stanley9.05%10,520,691$556.33MInstitution
Vanguard Group Inc7.56%8,783,621$464.48MInstitution
Baillie Gifford Co7.53%8,753,987$462.91MInstitution
Paladin Capital Management LLC4.83%5,617,583$297.06MInsider
Blackrock Inc4.51%5,239,107$277.04MInstitution
Fmr LLC3.76%4,372,294$231.21MInstitution
Bryan E. Roberts3.73%4,334,765$229.22MInsider
Ark Investment Management LLC3.58%4,155,323$219.73MInstitution
Softbank Vision Fund Aiv M2 LP3.30%3,836,232$202.86MInsider
Sands Capital Management LLC3.22%3,737,768$197.65MInstitution

1 of 3

TXG vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXG76.89%15.84%Net BuyingNet Buying
DOCS52.34%9.28%Net SellingNet Selling
RCM47.13%52.87%Net SellingNet Selling
HQY60.69%39.31%Net SellingNet Selling
TDOC82.50%6.96%Net SellingNet Selling

10x Genomics Stock Ownership FAQ

Who owns 10x Genomics?

10x Genomics (NASDAQ: TXG) is owned by 76.89% institutional shareholders, 15.84% 10x Genomics insiders, and 7.28% retail investors. Paladin Capital Management LLC is the largest individual 10x Genomics shareholder, owning 5.62M shares representing 4.83% of the company. Paladin Capital Management LLC's 10x Genomics shares are currently valued at $297.06M.

If you're new to stock investing, here's how to buy 10x Genomics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.